Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Qian Huang

Matched on ORCID iD 0000-0002-4474-3848; OpenAlex author ID A5060120779. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
37
Papers, trials and grants by year

2013: 3 papers · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 12

  1. Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer. Co-author DOI 10.1038/s41467-024-47242-3↗
  2. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinom… Co-author DOI 10.3389/fimmu.2023.1111494↗
  3. Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma. First author DOI 10.3389/fonc.2022.799475↗
  4. Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer. Co-author DOI 10.1186/s12943-020-01178-6↗
  5. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. Co-author DOI 10.1016/j.biomaterials.2018.01.014↗
  6. microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings. Co-author DOI 10.1186/s13046-018-0697-3↗
  7. microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2017.04.020↗
  8. Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. Co-author DOI 10.1016/j.bbcan.2016.08.002↗
  9. Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.molonc.2014.07.024↗
  10. The predictive role of p16 deletion, p53 deletion, and polysomy 9 and 17 in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s12253-012-9555-3↗
  11. Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.humpath.2012.04.014↗
  12. Etoposide induces apoptosis via the mitochondrial- and caspase-dependent pathways and in non-cancer stem cells in Panc-1 pancreatic cancer cells. First author DOI 10.3892/or.2013.2767↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jinfeng Zhu · 2 shared papers, 2022–2023 · strength 0.38
  2. Ling Tian · 5 shared papers, 2013–2020 · strength 0.37
  3. Mingjie Jiang · 4 shared papers, 2016–2020 · strength 0.36
  4. Dian-na Gu · 4 shared papers, 2016–2020 · strength 0.36
  5. Hua Jiang · 1 shared paper, 2023 · strength 0.22
  6. Qingqing Li · 1 shared paper, 2023 · strength 0.22
  7. Huamin Wang · 2 shared papers, 2018–2024 · strength 0.21
  8. Ya’an Kang · 2 shared papers, 2018–2024 · strength 0.21
  9. Jun Zhao · 2 shared papers, 2018–2024 · strength 0.21
  10. Jason B. Fleming · 2 shared papers, 2018–2024 · strength 0.21
  11. Anirban Maitra · 2 shared papers, 2018–2024 · strength 0.21
  12. Hongliang Luo · 1 shared paper, 2022 · strength 0.16
  13. Chen Huan Luo · 1 shared paper, 2022 · strength 0.16
  14. Chi Fang · 2 shared papers, 2017–2018 · strength 0.16
  15. Ping Chen · 1 shared paper, 2024 · strength 0.14
  16. Ching-Fei Li · 1 shared paper, 2024 · strength 0.14
  17. Jianhua Ling · 1 shared paper, 2024 · strength 0.14
  18. Kenei Furukawa · 1 shared paper, 2024 · strength 0.14
  19. Lu Yu · 1 shared paper, 2024 · strength 0.14
  20. Wenjuan Yin · 1 shared paper, 2024 · strength 0.14
  21. Jun Yao · 1 shared paper, 2024 · strength 0.14
  22. Jie Fu · 1 shared paper, 2024 · strength 0.14
  23. Paul J. Chiao · 1 shared paper, 2024 · strength 0.14
  24. Mien‐Chie Hung · 1 shared paper, 2024 · strength 0.14
  25. Peng Huang · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.